相关实验视频
Updated: May 21, 2025

08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
10.6K
在2022年波兰的百日咳
Agnieszka Rumik1, Iwona Paradowska-Stankiewicz1
1Zakład Epidemiologii Chorób Zakaźnych i Nadzoru, Narodowy Instytut Zdrowia Publicznego PZH - Państwowy Instytut Badawczy.
Przeglad epidemiologiczny
|March 18, 2025
概括
波兰的百日咳病例在COVID-19限制放松后,在2022年增加了104%. 保持高的疫苗接种率对于防止这种传染病在未来的流行病至关重要.
科学领域:
- 流行病学 流行病学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 百日咳 (百日咳) 仍然是一个重要的公共卫生问题,因为疫苗诱导的免疫力下降.
- 随着COVID-19大流行和随后的放宽限制,影响了 pertussis 的流行病学状况.
- 有效的百日咳预防依赖于及时的儿童免疫接种,成人强剂和母体疫苗接种.
研究的目的:
- 分析波兰2022年百日咳流行病学情况.
- 为了比较2022年百日咳的发病率与前几年.
- 评估大流行影响,评估儿童疫苗接种情况.
主要方法:
- 来自Epibaza系统 (NIPH NIH - NRI) 的个人百日咳病例报告的分析.
- 关于波兰传染病和疫苗接种的年度公告的审查.
- 来自"波兰传染病和中毒"和"2022年波兰疫苗接种"的数据汇编.
主要成果:
- 2022年记录了371例 pertussis病例,比2021年增加了104%,发生率为0.98/100,000.
- 在0-4岁 (6.7/100,000) 和5-9岁 (2.0/100,000) 的儿童中观察到的最高发病率.
- 超过51%的病例发生在15岁以上的个体中,41%需要住院治疗. 2岁儿童接种疫苗的比例为94.3%.
结论:
- 2022年百日咳病例的增加与放宽社会接触限制有关.
- 由于易受感染的个体增加,未来存在补偿性流行病的可能性.
- 保持全人口疫苗接种率高于95%对于预防百日咳至关重要.
关键词:
2022 年 2022 年 2022 年 2022 年 2022 年波兰 波兰 波兰 波兰波兰波兰人 波兰人疾病 zakaźnene 的意思.流行病学流行病学流行病学流行病学传染病是一种传染性疾病.克里斯图斯问了一个问题.pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis相关概念视频
Pulmonary Tuberculosis II
202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
Vaccinations
43.1K
Overview
43.1K
Pulmonary Tuberculosis I
214
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
214
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Pneumonia I: Introduction
201
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
201
Pulmonary Tuberculosis V
159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159

